معرفی
David Coelho is a Researcher at INSERM and Head of Groupe 2 (Team 1) at Université de Lorraine, located at Campus Brabois Santé. His primary affiliation is with the university and INSERM, focusing on research in monocarbon metabolism and rare diseases related to vitamin B12 metabolism. He holds a PhD from the University of Strasbourg (2002) and completed postdoctoral fellowships at the University Children’s Hospital Zürich (2011-2012) and Basel (2003-2010).
- Education:
- PhD in Biochemistry, University of Strasbourg (2002)
- Postdoctoral Research, University Children’s Hospital Zürich (2011-2012)
- Postdoctoral Research, University Children’s Hospital Basel (2003-2010)
Research interests include molecular mechanisms of vitamin B12-related disorders, metabolic pathways, and translational approaches using cellular and mouse models. He leads Team 1 and oversees technical platforms such as Molecular Biology, Functional Genomics, Immunomarkings-Microscopy, and Bioinformatics.
No scientific awards are explicitly mentioned. Current supervision includes Zeinab Alsahly’s PhD on iron nanoclusters for iron deficiency treatment (co-directed with F. Feillet).
Technical infrastructure includes access to advanced facilities like the Bio Data Center and analytical sectors, supporting interdisciplinary research in biochemistry and genetics.
